New treatment option for Asthma
Official title Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
ClinicalTrials.gov ID: NCT01225913
What this study is testing
What is fluticasone/salmeterol in all asthmatics?
fluticasone/salmeterol in all asthmatics is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for asthma.
Also referred to as symbicort 80/4.5, advair 100/50 or 250/50 or 500/50 bid.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to evaluate the site and mechanisms responsible for expiratory airflow limitation in chronic, treated, non-smoking, stable asthmatics with moderate to severe persistent expiratory airflow obstruction. Treatment will include inhaled corticosteroids and long acting beta2agonists.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 10 to 80
You may be able to join if
- Current non-smoking (\<10 pack yr smoking history)
- Stable, treated asthmatics
- Age 10-80 yr
- post 180ug albuterol by MDI: FEV 1/FVC \< 70% and FEV 1 \<80% predicted
You likely can't join if
- Pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Lakewood, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 10 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lakewood, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.